BLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug development
about
BLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug development
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
BLT2 is a pro-tumorigenic medi ...... r anti-cancer drug development
@ast
BLT2 is a pro-tumorigenic medi ...... r anti-cancer drug development
@en
BLT2 is a pro-tumorigenic medi ...... r anti-cancer drug development
@nl
type
label
BLT2 is a pro-tumorigenic medi ...... r anti-cancer drug development
@ast
BLT2 is a pro-tumorigenic medi ...... r anti-cancer drug development
@en
BLT2 is a pro-tumorigenic medi ...... r anti-cancer drug development
@nl
prefLabel
BLT2 is a pro-tumorigenic medi ...... r anti-cancer drug development
@ast
BLT2 is a pro-tumorigenic medi ...... r anti-cancer drug development
@en
BLT2 is a pro-tumorigenic medi ...... r anti-cancer drug development
@nl
P2093
P2860
P1476
BLT2 is a pro-tumorigenic medi ...... r anti-cancer drug development
@en
P2093
Jae In Park
Jae-Hong Kim
Jun Dong Wei
Nam-Kyu Cho
Young-Chul Joo
P2860
P304
P407
P577
2013-01-01T00:00:00Z